SC209 intermediate-2

• Description :

  SC209 intermediate-2 (Compound A9) is an intermediate of the ADC cytotoxin SC209 (HY-144880) . SC209 intermediate-2 is an ADC Linker[1].

• UNSPSC :

  12352203

• Hazard Statement :

  H302, H315, H319, H335

• Target :

  ADC Payload

• Type :

  ADC Related

• Related Pathways :

  Antibody-drug Conjugate/ADC Related

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/sc209-intermediate-2.html

• Purity :

  99.60

• Solubility :

  DMSO : 200 mg/mL (ultrasonic)

• Smiles :

  CC(C)(C1=CC(N)=CC=C1)[C@H](N(C)C(OC(C)(C)C)=O)C(N[C@@H](C(C)(C)C)C(N(C)[C@@H](C(C)C)/C=C(C)/C(OCC)=O)=O)=O

• Molecular Formula :

  C34H56N4O6

• Molecular Weight :

  616.83

• Precautions :

  H302, H315, H319, H335

• References & Citations :

  [1]Toni Kline, et al. Hemiasterlin derivatives for conjugation and therapy. Patent. WO2016123582.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  ADC Related

• Clinical Information :

  No Development Reported

• CAS Number :

  [1977557-83-7]